Leave No Stent Behind: Are Drug-Coated Balloons Enough for Femoropopliteal Disease?

Circ Cardiovasc Interv. 2018 Jan;11(1):e006285. doi: 10.1161/CIRCINTERVENTIONS.117.006285.

Authors

Sanjum S Sethi¹, Sahil A Parikh²

Affiliations

¹ From the Center for Interventional Vascular Therapy, Division of Cardiology, Department of Medicine, Columbia University Medical Center and New York Presbyterian Hospital.
² From the Center for Interventional Vascular Therapy, Division of Cardiology, Department of Medicine, Columbia University Medical Center and New York Presbyterian Hospital. sap2196@cumc.columbia.edu.

PMID: 29326156
DOI: 10.1161/CIRCINTERVENTIONS.117.006285

No abstract available

Keywords: Editorials; angioplasty; diabetes mellitus; hyperplasia; neointimal; nitinol; paclitaxel.

Publication types

Editorial
Comment

MeSH terms

Femoral Artery*
Popliteal Artery*
Stents